Sec Form 13D Filing - MHR FUND MANAGEMENT LLC filing for - 2026-01-27

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D



Comment for Type of Reporting Person:
The amounts listed above do not include (A) 7,035,969 Common Shares held by the Liberty Global Parties, of which the reporting persons may be deemed to have beneficial ownership as a result of the Liberty Global Voting Agreement or (B) 37,548,125 Common Shares held by the Liberty Entities, of which the reporting persons may be deemed to have beneficial ownership as a result of the Liberty77 Voting Agreement. See Item 5 and Item 6 of this Schedule 13D. This statement on Schedule 13D (this "Statement") amends and supplements, as Amendment No. 1 ("Amendment No 1"), the Schedule 13D filed on May 8, 2025 (the "Original Schedule 13D" and together with Amendment No. 1, the "Schedule 13D") and relates to Common Shares, no par value per share (the "Common Shares"), of Lionsgate Studios Corp. Except as otherwise provided, capitalized terms used in this Statement but not defined herein shall have the respective meanings given to such terms in the Original Schedule 13D.


SCHEDULE 13D

 
MHR INSTITUTIONAL PARTNERS III LP
 
Signature:/s/ Janet Yeung
Name/Title:Authorized Signatory
Date:01/27/2026
 
MHR Institutional Advisors III LLC
 
Signature:/s/ Janet Yeung
Name/Title:Authorized Signatory
Date:01/27/2026
 
MHR Fund Management LLC
 
Signature:/s/ Janet Yeung
Name/Title:Authorized Signatory
Date:01/27/2026
 
MHR HOLDINGS LLC
 
Signature:/s/ Janet Yeung
Name/Title:Authorized Signatory
Date:01/27/2026
 
Mark H. Rachesky, M.D.
 
Signature:/s/ Janet Yeung
Name/Title:Attorney-in-Fact
Date:01/27/2026
primary_doc.xml